Image – Interventional flashlight

DOI: 10.4244/EIJ-D-23-00426

Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation

Kerstin Piayda1, MD, MSc; Mani Arsalan1,2, MD; Peter Roth3, MD; Oliver Dörr1, MD; Christian Hamm1, MD; Holger Nef1, MD; Andreas Böning3, MD

A 73-year-old woman presented with severe mitral regurgitation and New York Heart Association (NYHA) Class IV symptoms. The patient was discussed in our Heart Team and deemed inoperable due to frailty and high surgical risk (Society of Thoracic Surgeons [STS] score: 15.1%). Transoesophageal echocardiography (TOE) showed severe mitral valve regurgitation with a diminutive posterior mitral valve leaflet and consecutive restricted leaflet motion (Moving image 1). An edge-to-edge repair was therefore not considered, but analysis of a full cardiac cycle by computed tomography depicted suitability for Tendyne (Abbott) implantation. Computational modelling revealed a high risk of left ventricular outflow tract obstruction (LVOTO) due to the excessive length (2.8 cm) of the anterior mitral valve leaflet (AML) and small LVOT dimensions (Figure 1A, Moving image 2). In the past, patients with a very tethered, floppy or long AML have been deemed unsuitable for Tendyne implantation: the covered prosthesis holds the native leaflets open during the whole cardiac cycle, and during early systolic outflow, the aforementioned, high-risk AML features can contribute to a “parachute configuration” of the native leaflet with a risk of LVOTO. To reduce the risk of systolic anterior movement post-implantation, AML modification is required.

A fairly new transapical, TOE-guided approach for AML laceration was considered, which has only been reported in one other clinical case1. The here presented case, however, offers pathophysiological insights as to why AML modification is necessary even for the implantation of a covered prosthesis like the Tendyne, and we provide the short-term clinical and echocardiographic follow-up.

After gaining transapical access, which is the standard access route for Tendyne, a surgical endoscopic scissor (CLICKLine; Karl-Storz) was inserted (Figure 1B, Moving image 3, Moving image 4) and positioned via a 26 Fr DrySeal sheath (W.L. Gore & Associates) into the left atrium, directly above the mitral valve annular plane. The stepwise pulling back of the sheath resulted in the insertion of the AML into the endoscopic scissor. After an echo-guided confirmation of the correct scissor position, directly underneath the anterior leaflet, successful cutting of the AML was achieved (Figure 1C) resulting in higher-grade mitral valve regurgitation (Moving image 5). Afterwards, a 29L LP Tendyne valve was successfully implanted (Figure 1D) without any complications. The final perioperative imaging assessment showed good anchoring of the valve with no leakage and a mean gradient of 4 mmHg. At 30 days, the patient presented with a substantially improved functional capacity (NYHA II), excellent prosthesis valve function and no relevant LVOTO (gradient 9 mmHg).

Figure 1. Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation. A) Computed tomography modelling of the Tendyne (Abbott) prosthesis with 3mensio (Pie Medical) revealed the predicted small neo-LVOT dimensions (area of 181.1 mm2) complicated by high-risk AML features favouring systolic anterior movement of the native leaflet post-implant. B) Fluoroscopic view of scissor insertion (left) and scissor placement (TOE LVOT view, right). C) Laceration of the anterior mitral leaflet (white asterisk). D) 3D-TOE view after final valve deployment. 3D: three-dimensional; AML: anterior mitral valve leaflet; LVOT: left ventricular outflow tract; TOE: transoesophageal echocardiography

Conflict of interest statement

A. Boening has received speaker honoraria from Abbott and is a co-founder of the Mitralklappen D/EU gGmbH. The other authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. 3D-TOE surgical view of the mitral valve depicting a diminutive posterior mitral valve leaflet and consecutive restricted leaflet motion.

Moving image 2. Computational modelling of the Tendyne prosthesis position.

Moving image 3. 2D-TOE X-plane view of endoscopic scissor advancement from the apex.

Moving image 4. 3D-TOE reconstruction of the endoscopic scissor advancement (surgical view).

Moving image 5. 3D-TOE surgical view of the mitral valve showing high-grade mitral valve regurgitation after anterior mitral valve leaflet modification with endoscopic scissors.

Volume 19 Number 9
Nov 17, 2023
Volume 19 Number 9
View full issue


Key metrics

Suggested by Cory

MITRAL VALVE INTERVENTIONS

10.4244/EIJV12SYA20 Sep 18, 2016
Transcatheter mitral valve implantation: Tendyne
Moat N et al
free

Editorial

10.4244/EIJ-E-24-00002 Mar 4, 2024
Catheter-based versus surgical mitral valve intervention: choosing between the red pill and the blue pill
Bagur R and McInerney A
free

Research correspondence

10.4244/EIJ-D-21-00745 Apr 22, 2022
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification
Gössl M et al
free

10.4244/EIJV11SWA23 Sep 17, 2015
The Tendyne transcatheter mitral valve implantation system
Perpetua E and Reisman M
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved